Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 0.0 | 0.0 | 0.5 | 0.0 |
| Revenue growth | | -100.0% | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.5 | 0.0 |
| Gross margin | | | 100.0% | |
| Research and development | 8.3 | 7.9 | 4.5 | 3.2 |
| General and administrative | 4.4 | 3.7 | 2.7 | 1.3 |
| EBIT | -12.7 | -11.6 | -6.8 | -4.5 |
| EBIT margin | | | -1352.2% | |
| Pre-tax income | -12.3 | -10.6 | -5.7 | -4.3 |
| Income taxes | 0.0 | 0.0 | 0.1 | 0.0 |
| Tax rate | | | | 0.0% |
| Net income | -12.3 | -10.6 | -5.7 | -4.3 |
| Net margin | | | -1146.8% | |
| |
| Diluted EPS | ($0.78) | ($0.89) | ($0.74) | ($0.72) |
| Shares outstanding (diluted) | 15.7 | 12.0 | 7.7 | 5.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|